![June McLenaghan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
June McLenaghan
No más puestos en curso
Perfil
June McLenaghan worked as an Operations Director at Xceleron Ltd.
from 2003 to 2013.
She also worked as a Senior Analyst at K.S.
Biomedix Holdings Plc and Unipath Ltd.
Ms. McLenaghan obtained an undergraduate degree from The University of Stirling.
Antiguos cargos conocidos de June McLenaghan.
Empresas | Cargo | Fin |
---|---|---|
Xceleron Ltd.
![]() Xceleron Ltd. Miscellaneous Commercial ServicesCommercial Services Xceleron Ltd. provides bioanalytical Accelerator Mass Spectrometry (AMS) services for accelerated early drug development. The company uses ultra-sensitive AMS to investigate the pharmacokinetics and metabolism of developmental drugs in Phase 0, Phase I and Phase II/III clinical trials. It was founded in 1997 and is located in York, the United Kingdom. | Director de Operaciones | 24/01/2013 |
K.S. Biomedix Holdings Plc | Corporate Officer/Principal | - |
Unipath Ltd.
![]() Unipath Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, Unipath Ltd. is a British company that manufactures female healthcare products. The company is based in Bedford, UK. The company was founded in 1946 by Paul James Davis. Unipath was acquired by Alere, Inc. from Unilever NV on 2001-12-20 for $146.54 million. | Corporate Officer/Principal | - |
Formación de June McLenaghan.
The University of Stirling | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 3 |
---|---|
Xceleron Ltd.
![]() Xceleron Ltd. Miscellaneous Commercial ServicesCommercial Services Xceleron Ltd. provides bioanalytical Accelerator Mass Spectrometry (AMS) services for accelerated early drug development. The company uses ultra-sensitive AMS to investigate the pharmacokinetics and metabolism of developmental drugs in Phase 0, Phase I and Phase II/III clinical trials. It was founded in 1997 and is located in York, the United Kingdom. | Commercial Services |
Unipath Ltd.
![]() Unipath Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, Unipath Ltd. is a British company that manufactures female healthcare products. The company is based in Bedford, UK. The company was founded in 1946 by Paul James Davis. Unipath was acquired by Alere, Inc. from Unilever NV on 2001-12-20 for $146.54 million. | Health Technology |
K.S. Biomedix Holdings Plc | Health Technology |
- Bolsa de valores
- Insiders
- June McLenaghan